Research at Fox Chase »Research Programs »Research Areas

Researcher	Research Area
Angela R Bradbury, MD	Director, Margaret Dyson Family Risk Assessment Program Primary research focus areas are ethical dilemmas in the cancer prevention field and predictive genetic testing Research on how and when parents communicate their BRCA (breast cancer gene) mutation status to their children and the impact of early communication of genetic risk on children's health behaviors
Mary B Daly, MD, PhD	Program Leader Senior Vice President, Population Science Division Education, risk assessment, and evaluation of screening and prevention programs for individuals with a family history of cancer through The Margaret Dyson Family Risk Assessment Program (FRAP) Education directed towards women with benign breast disease through The Benign Breast Registry to Assess Valid Endpoints (BeBrave) Program
Veda N Giri, MD	Director, Prostate Cancer Risk Assessment Program Awarded the Special Interest Award by ACS to investigate the role of DNA mismatch repair defects in prostate cancer susceptibility Ongoing research into the genetic, molecular and proteomic pathways involved in cancer susceptibility, especially prostate cancer
Andrew K Godwin, PhD	Director, Clinical Molecular Genetics Laboratory Director, Biosample Repository Member, Medical Science Division Member, Department of Medical Oncology Primary focus directed at improving the understanding of the etiology of several types of cancer and assessing molecular-targeted therapies for the treatment of these diseases. Studies primarily involve three different types of cancer, gastrointestinal stromal tumors (GISTs), ovarian, and breast
Stuart R Lessin, MD	Director, Dermatology-Cutaneous Oncology Program Senior Member, Medical Science Division Clinical research program established to investigate various aspects of cutaneous oncology. Skin cancers under investigation include melanoma, cutaneous T-cell lymphoma, and non-melanoma skin cancer (basal/squamous cell carcinoma)
Neal J Meropol, MD	Director, Gastrointestinal Cancer Program Director, Gastrointestinal Tumor Risk Assessment Program (GI-TRAP) to help individuals who are at increased risk for colon and other GI cancers Ongoing study of new therapies and ways to improve the communication between doctors and patients to end up with the best treatment decisions
Mary E Ropka, PhD, RN, FAAN	Associate Member, Population Science Division Research focuses on understanding the diverse and multiple decisions that individuals and families face when dealing with hereditary cancer risk (HCR)
Eric A. Ross, PhD	Senior Director, Academic Informatics Associate Member Primary focus involves the use of information technology and quantitative methods in support of clinical, population and basic research
David S Weinberg, MD, MSc	Chair, Department of Medicine Research focus on cancer prevention, especially for patients who are at average risk for gastrointestinal cancers.